2. UroToday Home
  3. Video Lectures

Leaders in Radiopharmaceuticals: Disruptive Innovations and Personal Perspectives

Developing Radium-223: From Bone Metastases to Systemic Radiopharmaceuticals - Øyvind Bruland
October 24, 2024
Details
Lead-212 Radiopharmaceuticals Offer Promise in Targeted Cancer Treatment - Volker Wagner
October 22, 2024
Details
Radiopharmaceutical Innovations Transforming Cancer Treatment Landscape - Jeffrey Humphrey
October 21, 2024
Details
Future of Cancer Treatment: New Targets and Isotopes in Theranostics - Martin Pomper
October 19, 2024
Details
Combining Nuclear Medicine and Immunotherapy for Enhanced Cancer Treatment - Chris Behrenbruch
September 17, 2024
Details
Understanding Isotopes and Targets Key in Radiopharmaceutical Therapy - Jessica Jensen
September 16, 2024
Details
Expanding Radiopharmaceuticals for Cancer Treatment: Addressing Supply and Manufacturing Challenges - Charles Conroy
September 5, 2024
Details
Theranostics Revolution: Shaping the Future of Cancer Treatment - Sergio Calvo
September 5, 2024
Details
Exploring Actinium-225: Transforming Cancer Treatment with Targeted Radiopharmaceuticals - John Valliant
September 3, 2024
Details
Lead-212 Radiopharmaceuticals: Advancing Targeted Alpha Therapy in Oncology - Anna Karmann
August 29, 2024
Details
Advancing Radiopharmaceuticals: Targeting Strategies and Isotope Selection in Cancer Therapy - John Babich
August 9, 2024
Details
Advancing Radiopharmaceuticals: Isotopes, Targets, and Challenges - Germo Gericke
August 5, 2024
Details
Copper-67 (Cu-67 or 67Cu) in Cancer Therapy: Current Developments and Future Potential - Alan Taylor
July 31, 2024
Details
Advancing Radiopharmaceuticals: From Lead-212 to Pre-Targeting Strategies - Michael Schultz
July 31, 2024
Details
Radiopharmaceuticals and Combination Approaches in Advancing the Prostate Cancer Treatment Landscape - Philip Kantoff
July 30, 2024
Details
Lead-212 Radiopharmaceuticals: Next Frontier in Cancer Treatment - Emanuele Ostuni
July 30, 2024
Details